| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |